Securities code: Beijing Scitop Bio-Tech Co.Ltd(300858) securities abbreviation: Beijing Scitop Bio-Tech Co.Ltd(300858) Announcement No.: 2022022 Beijing Scitop Bio-Tech Co.Ltd(300858)
Special report on the deposit and actual use of raised funds in 2021
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
In accordance with the guidelines for the supervision of listed companies No. 2 – regulatory requirements for the management and use of raised funds by listed companies issued by the CSRC and the guidelines for the self-discipline supervision of listed companies on the Shenzhen Stock Exchange No. 2 – standardized operation of companies listed on the gem issued by the Shenzhen Stock Exchange, The board of directors of Beijing Scitop Bio-Tech Co.Ltd(300858) (hereinafter referred to as “the company”) has prepared a special report on the annual deposit and actual use of raised funds as of December 31, 2021. 1、 Basic information of raised funds
1. Actual amount of funds raised and time of funds in place
Approved by the reply on approving Beijing Scitop Bio-Tech Co.Ltd(300858) initial public offering (zjxk [2020] No. 1337) of China Securities Regulatory Commission, the company issued 20630000 ordinary shares (A shares) in the initial public offering of RMB, with a par value of RMB 1.00 per share, an issue price of RMB 23.70 per share and a total raised capital of RMB 488931000. After deducting the issuance expenses excluding tax, The net amount of funds raised by the company this time is RMB 436181500. The balance of the above total raised funds after deducting the unpaid recommendation and underwriting fees (including tax) was transferred to the designated account of the company on July 21, 2020. Zhongshen Zhonghuan Certified Public Accountants (special general partnership) has issued the capital verification report (Zhong Huan Yan Zi [2020] No. 010029) on July 21, 2020.
2. Utilization and balance of raised funds in 2021
Unit: 10000 yuan
Project amount
Project amount
Total raised funds 4889310
Less: issuance fee paid in 2020: 492215
Less: 415.09 yuan of issuance expenses paid in the early stage of replacement with raised funds in 2020
Less: use amount of raised investment projects in 20202804.74
Less: 3403700 yuan for cash management with idle raised funds in 2020
Less: investment in the early stage of replacement of raised funds in 20208460.38
Less: 0.20 of bank handling charges paid in 2020
Plus: the amount of idle raised funds recovered for cash management in 2020 was 1199700
Plus: interest income in 2020: 102.32
Plus: cash management income in 2020: 75.21
As of December 31, 2020, the balance of the special account for raised funds was 1042808 yuan
Less: use amount of raised investment projects in this year: 435101
Less: the amount of cash management using idle raised funds in this year is 7245000
Less: the closing balance of the special account for raised funds this year was transferred to the basic account by 0.11
Less: the amount of bank handling charges paid this year is 0.24
Plus: the amount of idle raised funds recovered for cash management in this year is 9449000
Plus: interest income of this year: 79.55
Add: cash management income of this year: 872.23
As of December 31, 2021, the balance of the special account for raised funds was 2906850
2、 Deposit and management of raised funds
1. Management of raised funds
In order to standardize the management of the company’s raised funds and improve the efficiency of the use of the raised funds, in accordance with the company law of the people’s Republic of China, the securities law of the people’s Republic of China, the guidelines for the supervision of listed companies No. 2 – regulatory requirements for the management and use of the raised funds of listed companies, the Listing Rules of GEM stocks of Shenzhen Stock Exchange, the guidelines for the standardized operation of GEM listed companies of Shenzhen Stock Exchange and other laws and regulations In accordance with the relevant provisions of normative documents and Beijing Scitop Bio-Tech Co.Ltd(300858) articles of association, the company has formulated the measures for the management of raised funds. According to the provisions of the above system, the company implements a special account for the raised funds according to each investment project.
The second and fourth meetings of the board of directors of Beijing Branch approved the fund raised by huai8 35 Manage, use and sign the tripartite supervision agreement on raised funds (hereinafter referred to as the “tripartite supervision agreement”) with the above-mentioned bank and the sponsor Credit Suisse Founder Securities Co.Ltd(601901) Co., Ltd., which is not significantly different from the model tripartite supervision agreement.
In view of the fund-raising investment project of the project with an annual output of 30 tons of lactic acid bacteria powder, 45 tons of solid drinks, 45 tons of tablet candy and 10 tons of ready to eat lactic acid bacteria, the project is implemented by Jinhua Yinhe Biotechnology Co., Ltd. (hereinafter referred to as “Jinhua Yinhe”), a wholly-owned subsidiary of the company. In order to standardize the fund-raising management of the company and protect the rights and interests of investors, In accordance with relevant laws and regulations and the provisions of the guidelines for self discipline supervision of Listed Companies in Shenzhen Stock Exchange No. 2 – standardized operation of companies listed on GEM, the company has signed the four party supervision agreement on raising funds with Jinhua galaxy, Industrial And Commercial Bank Of China Limited(601398) Jinhua Branch and the sponsor Credit Suisse Founder Securities Co.Ltd(601901) Co., Ltd.
On April 21, 2021, the company held the 9th meeting of the 2nd board of directors, the 9th meeting of the 2nd board of supervisors and the 2020 annual general meeting of shareholders held on June 3, 2021, deliberated and adopted the proposal on changing some investment projects with raised funds and establishing wholly-owned subsidiaries and providing loans to implement the investment projects with raised funds, which will be the “production project with an annual output of 10000 tons of food ingredients” The “production project of animal husbandry and agricultural micro ecological products with an annual output of 8000 tons” and the “construction project of science and technology R & D center” are adjusted for the “food sector R & D and production base project” and “micro ecological agent production base project”. Since the fund-raising investment project of the R & D and production base project of the food sector is implemented by Inner Mongolia Beijing Scitop Bio-Tech Co.Ltd(300858) Co., Ltd. (hereinafter referred to as “Inner Mongolia Ketuo”), a wholly-owned subsidiary of the company, and the fund-raising investment project of the microecological preparation production base project is implemented by Inner Mongolia guketuo Micro Ecological Technology Development Co., Ltd. (hereinafter referred to as “Ketuo micro ecology”), a wholly-owned subsidiary of the company, in order to standardize the fund-raising management of the company, To protect the rights and interests of investors, in accordance with relevant laws and regulations and the provisions of the guidelines for self discipline supervision of Listed Companies in Shenzhen Stock Exchange No. 2 – standardized operation of companies listed on the gem, the company and Inner Mongolia Ketuo, Bank Of Communications Co.Ltd(601328) Hohhot Ulan sub branch, the sponsor credit Suisse Founder Securities Co.Ltd(601901) Co., Ltd., as well as Ketuo micro ecology, China Merchants Bank Co.Ltd(600036) Hohhot University East Street sub branch The sponsor Credit Suisse Founder Securities Co.Ltd(601901) Co., Ltd. signed the four party supervision agreement on raised funds respectively.
2. Storage of raised funds in special account
As of December 31, 2021, the balance of the special account for the deposit of raised funds is as follows:
Opening bank account balance (10000 yuan) remarks
Industrial And Commercial Bank Of China Limited(601398) Beijing Yanqi Economic Development Zone sub branch 02 Shenzhen Mingdiao Decoration Co.Ltd(002830) 192 Tianma Microelectronics Co.Ltd(000050) 9294139.27 current account
Bank Of Ningbo Co.Ltd(002142) Beijing Wangjing sub branch 77060122001740748578.37 current account
Opening bank account balance (10000 yuan) remarks
Bank Of Hangzhou Co.Ltd(600926) Beijing Beijing Centergate Technologies (Holding) Co.Ltd(000931) sub branch 11010401 Shanxi Lanhua Sci-Tech Venture Co.Ltd(600123) 62304643.25 current account
Bank Of Communications Co.Ltd(601328) Hohhot Ulan sub branch 1510 Xiamen R&T Plumbing Technology Co.Ltd(002790) 1 Walvax Biotechnology Co.Ltd(300142) 4102079.75 current account
China Merchants Bank Co.Ltd(600036) Hohhot University East Street sub branch 4719019166107019627.86 current account
Industrial And Commercial Bank Of China Limited(601398) Beijing Huairou sub branch 02 Suncha Technology Co.Ltd(001211) 9200537191 account cancellation
China Citic Bank Corporation Limited(601998) Beijing Shilihe sub branch 8110701013101928319 account cancellation
Industrial And Commercial Bank Of China Limited(601398) Jinhua Branch 1208017029200618836 account cancellation
Total 2906850
3、 Actual use of raised funds this year
1. Use of funds for investment projects with raised funds.
The actual use of the raised funds in this year is shown in the “comparison table of the use of raised funds” (Schedule 1). 2. Changes in the place and mode of implementation of the project invested with raised funds.
Not applicable.
3. Advance investment and replacement of investment projects with raised funds.
Not applicable.
4. Temporarily replenish working capital with idle raised funds.
Not applicable.
5. Utilization of surplus raised funds.
Not applicable.
6. Use of over raised funds.
Not applicable.
7. Purpose and destination of unused raised funds.
The company held the fifth meeting of the second board of directors and the fifth meeting of the second board of supervisors on August 26, 2020 and the first extraordinary general meeting of shareholders in 2020 on September 18, 2020, deliberated and adopted the proposal on cash management with idle raised funds, and agreed that the company would not affect the normal construction of raised investment projects, It is proposed to use idle raised funds with a total amount of no more than RMB 300 million (including this amount) for cash management. The above amount will be effective within 12 months from the date of deliberation and approval at the first extraordinary general meeting of shareholders in 2020. Within the above-mentioned limit and term, the funds can be used in a circular and rolling manner. The independent directors of the company have expressed their independent opinions on this matter, and the sponsor Credit Suisse Founder Securities Co.Ltd(601901) Co., Ltd. has issued clear verification opinions on this matter.
The company held the 11th meeting of the second board of directors, the 10th meeting of the second board of supervisors and the second extraordinary general meeting of shareholders in 2021 on July 8, 2021, deliberated and adopted the proposal on cash management with idle raised funds, and agreed that the company would not affect the normal construction of raised investment projects, It is proposed to use idle raised funds with a total amount of no more than RMB 270 million (including this amount) for cash management. The above amount will be effective within 12 months from the date of deliberation and approval at the second extraordinary general meeting of shareholders in 2021. Within the above-mentioned limit and term, the funds can be used in a circular and rolling manner. common
